Background Twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs)
may reduce drug adherence compared with once-daily dosing of NOACs in patients with …

Background and Objectives Nonvitamin K antagonist oral anticoagulants (NOACs) require
stricter medication adherence. We investigated the NOACs adherence in real-world practice …

Aims To investigate the association between adherence to non-vitamin K antagonist oral
anticoagulant (NOAC) and clinical outcomes and to determine the optimal cut-off level of …

Introduction Treatment adherence and persistence impact the effectiveness of edoxaban for
the prevention of thromboembolism in patients with atrial fibrillation (AF). The objective of …

Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …

Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …

Aims The purpose of this study was to describe adherence with non-vitamin K antagonists
(NOACs) and vitamin K antagonists (VKA) in patients with non-valvular atrial fibrillation …

Introduction: In the treatment of non-valvular atrial fibrillation (AF) with oral anticoagulant
(OAC), the patients' adherence to therapy is a very important factor in stroke prevention. Aim …

Background Nonadherence diminishes the efficacy of direct oral anticoagulants (DOACs) in
patients with nonvalvular atrial fibrillation (NVAF). This report presents the baseline survey …

Background Differences in adherence may represent drug properties (eg dosing interval) or
patient experiences while on treatment. Adherence to direct oral anticoagulants (DOACs) in …